Wearables Useless on Hormonal Therapy GLP-1 Fluctuating Hormones

The little red number on your phone screen every morning is lying to you. The algorithm assumes your autonomic nervous system operates in a static environment, making it utterly blind to the biological realities of hormonal therapy, GLP-1s, and the menstrual cycle. I used to trust my device implicitly, until I realised I was punishing myself for standard endocrine fluctuations.

You wake up feeling relatively fine, maybe a little stiff, but capable. Then you open the app, see a glaring red circle, and suddenly you feel a strange, creeping exhaustion. Your device says your recovery is terrible, even though your only crime was taking your weekly semaglutide injection or entering the luteal phase of your cycle. You spend the rest of the day second-guessing your own body. You feel tired but wired, pushing through the afternoon with a low-grade hum of dread. At night, you can't sleep even though exhausted, staring at the ceiling and wondering why you feel anxious for no reason. You start skipping workouts, convinced you are overtraining, while dealing with brain fog and a jaw so tight it aches by 3pm. The screen has convinced you that your internal machinery is broken.

Common Questions

Why does my wearable give me weird readings on HRT or GLP-1s?

Hormonal medications directly alter your resting heart rate and heart rate variability. The software on your wrist is programmed using population averages. When your medication shifts your autonomic state into a slightly higher gear, the device misinterprets this new normal as a sign of acute stress.

Is HRV data useless if my hormones fluctuate?

The raw data is still accurate, but the app's interpretation of it is flawed. The metric simply reflects the reality of your current endocrine state. You have to ignore the warning colours and learn to read the numbers as neutral information about your biology.

What is a better way to track my recovery?

Use the device to establish a personal trendline over thirty days, ignoring the daily warnings. Cross-reference those numbers with how your joints feel, your energy levels, and your mood before you ever look at a screen.

The Quantified Self, Quantifying Its Own Blind Spots

The entire quantified-self industry operates on a remarkably rigid premise. It assumes the human body is a closed, stable system, and that any deviation from your usual heart rate means you are either sick, stressed, or hungover. If you have a stable, male-by-default, hormonally predictable body, this works. For everyone else, it provides a beautifully designed way to feel like you're failing.

Your heart rate climbs by three beats per minute after your first month on a GLP-1 agonist, and the app decides you're in physiological distress. Your heart rate variability drops on day twenty-two of your cycle, and you get a push notification telling you to take a rest day. These are normal biological adaptations to a changing chemical environment. The device simply lacks the vocabulary to understand the difference, creating a massive gap in modern nervous system regulation.

How GLP-1s Rewrite Your Autonomic State

If you take a GLP-1 receptor agonist like semaglutide or tirzepatide, you've likely noticed your heart rate feels a little faster. These medications do more than quiet the food noise in your brain and delay gastric emptying. They bind to receptors all over your body, including the sinoatrial node—the natural pacemaker of your heart.

The drug directly nudges your autonomic 'idle' speed slightly higher. It shifts your physiology into a mildly elevated sympathetic state. Your ring, totally unaware of your medication, sees this elevated heart rate, cross-references it with your previous numbers, and concludes you're chronically under-recovered. It takes a lot of mental discipline to ignore a flashing red screen, but understanding this systemic shift is the entire basis of the GLP-1 Anchor. Everyone focuses on the scale dropping. Nobody warns you that your wearable is going to scream at you for six months while your body adapts to the new load.

HRV Across the Cycle: The Data Your App Forgets

The influence of hormones on your autonomic state is standard endocrinology, though you'd never guess that from looking at a dashboard designed in Silicon Valley. During the follicular phase—the first half of your menstrual cycle—estrogen enhances vagal tone, pulling your heart rate variability up. In the luteal phase, as progesterone rises, vagal activity naturally dials back, and HRV drops.

The same erratic fluctuations happen during perimenopause or when you adjust an HRT patch. Your nervous system is reacting exactly as it should to the hormones circulating in your blood. I spent a year adjusting my training to match an app that was simply measuring my normal luteal phase. I had to relearn how to listen to my own muscles and tune out the digital noise, a process Kokorology teach heavily inside the Performance L2 course.

NERD OUT: Why Optical Sensors Struggle with Hormonal Noise

The hardware itself is flawed. Consumer devices don't use an electrocardiogram to measure the true electrical activity of your heart. They rely on photoplethysmography (PPG), which shines a green or red light into your wrist or finger to measure changes in blood volume. The algorithm then guesses your beat-to-beat interval from that optical signal.

Now introduce hormonal flux. Estrogen is a vasodilator; it widens your blood vessels. This physical change alters the blood volume signal the sensor receives. You're asking a tiny light bulb to accurately measure your nervous system through blood vessels that keep changing size. It's no wonder the data gets murky. The device is trying to measure the shadow of a pulse while you keep changing the shape of the object casting it.

The screen gives you a number. Your body gives you the context. Only one of them actually knows what it feels like to wake up in your bed today.

What to do this week

Chasing a perfect metric is madness. Change your relationship with the data.

1. Establish a new normal. If you start a GLP-1 or HRT, give your body at least a month to adjust. Ignore the daily warnings and watch the thirty-day trendline to find your new resting heart rate.
2. Track your cycle against the data. Note your menstrual phase next to your HRV reading to map your natural biological rhythm. You'll likely see a predictable pattern emerge that has nothing to do with your workout intensity.
3. Check in before you look at the screen. Score your own energy and mood out of ten before you open the app. Notice the discrepancies.
4. Adjust your programming. Stop skipping workouts just because an algorithm flashing red told you to rest. Trust your physical capability.

Where this fits in the Kokorology system

Moving beyond simplistic tech metrics requires a deeper understanding of your own physiology. This approach sits at the centre of the Library deep dives into autonomic function. It is also how Kokorology train coaches to interpret data correctly inside the Certifications program.

Closing

The goal is to demote your expensive gadget. Move it from the role of an absolute authority to an interesting, occasionally confused consultant. The device gives you a number; your body gives you the context. Learning to listen to the context is the real skill.

• Start with: The GLP-1 Anchor, a complete system for supporting your body on semaglutide.
• Practice it daily inside: The Journal, to finally calibrate device data against felt sense.
• Get the brief: the free weekly newsletter with one clear idea for your nervous system.

TL;DR

Your wearable device will likely give you inaccurate recovery warnings if your hormones fluctuate due to GLP-1s, HRT, or your menstrual cycle. These factors change your resting heart rate and heart rate variability, which the device’s algorithm misinterprets as acute stress. The raw data remains useful, but you cannot trust the app's interpretation of it. Use the numbers to establish your own physiological trendline, and rely on your actual felt sense as the primary indicator of your capacity for the day.

Sources

• Jastreboff AM (2022). SURMOUNT-1: Tirzepatide once weekly. New England Journal of Medicine.
• Prado CM (2025). Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation. Lancet Diabetes & Endocrinology.
• Maki PM (2020). Menopause and brain health: Hormonal changes are only part of the story. Frontiers in Neurology.
• de Jager S (2026). Wearable-Derived Heart Rate Variability Across the Menstrual Cycle, Hormonal Contraceptive Use, and Reproductive Stages: A Systematic Review. Sports Medicine.
• Dial MB (2025). Validation of nocturnal resting heart rate and heart rate variability in consumer wearables. Physiological Reports.